Cargando…
Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart disease
OBJECTIVE: Laboratory tests including optical platelet aggregometry (OPA), platelet function analyser (PFA-100), and thromboxane B(2) (TXB(2)) metabolite levels have been used to define aspirin resistance. This study characterised the prevalence of aspirin resistance in patients with ischaemic heart...
Autores principales: | Muir, A R, McMullin, M F, Patterson, C, McKeown, P P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705011/ https://www.ncbi.nlm.nih.gov/pubmed/18697805 http://dx.doi.org/10.1136/hrt.2008.150631 |
Ejemplares similares
-
Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial
por: Jorstad, Harald T, et al.
Publicado: (2013) -
The ischaemic constellation: an alternative to the ischaemic cascade—implications for the validation of new ischaemic tests
por: Maznyczka, Annette, et al.
Publicado: (2015) -
Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK
por: Crowe, Francesca, et al.
Publicado: (2020) -
Revascularisation for Ischaemic Cardiomyopathy
por: Li Kam Wa, Matthew E, et al.
Publicado: (2023) -
Associations of health-related quality of life with major adverse cardiovascular and cerebrovascular events for individuals with ischaemic heart disease: systematic review, meta-analysis and evidence mapping
por: Soloveva, Anzhela, et al.
Publicado: (2023)